This Week Last Year in Medtech: May 14-20

2023-05-18

临床申请上市批准

Medtronic Wins FDA Nod for Onyx Frontier DES

The Dublin-based company said the device is the latest innovation in the Resolute DES family.

Babson Has Friends in High Places

The blood-testing startup that's trying to succeed where Theranos failed has expanded its strategic partnership with the sixth largest medtech company in the world.

MannKind Acquires Wearable Insulin Device from Zealand Pharma

The Danbury, CT-based company said it was picking up the V-Go wearable $10 million.

An At-Home Collection Device for Diabetes Risk Testing

Labcorp and Weavr teamed up for the development of the at-home-collection device.

Medtronic Wants to Ease Your Pain with Closed-Loop Implantable

A prospective study will evaluate the long-term performance of a closed-loop algorithm with Medtronic’s investigative rechargeable neurostimulator.

Stryker Is Smart to Pursue This Type of Reimbursement

CMS recently established a new code for outpatient hospitals and ambulatory surgery centers to report the insertion of Stryker's InSpace balloon implant.

Medtronic Touts Cusp Overlap Technique in TAVR

Mid-term results of the Optimize PRO clinical study underscores predictability and control using the cusp overlap technique during transcatheter aortic valve replacement (TAVR) with Medtronic TAVR devices.

The Robot Will Do Your Angioplasty Now

Study results show promise for robotic coronary angioplasties using Robocath's R-One robot.

J&J MedTech Lands Clearance for Inhance Shoulder System

This clearance is in addition to the system’s already cleared use in anatomic shoulder arthroplasty.

Abbott Heart Valve Data Shines at EuroPCR

The data support the use of the company's TriClip tricuspid heart valve repair device, and Navitor, Abbott's transcatheter aortic valve implantation system.

NeuroOne’s Bid for Long-term Use of Evo sEEG Shot Down by FDA

The Eden Praire, MN-based company called the decision disappointing but said it would collect more data and submit for a Special 510 (k).

Has Medtech Shifted to a Seller's Strike?

Analyst says both the number and dollar volume of medtech M&A deals are likely to drop in 2022, compared to 2021.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构